Navigation Links
Chemoembolization Improving as Liver Cancer Treatment
Date:1/19/2009

these microspheres absorb the chemotherapeutic agent, and then the drug is released directly into the tumor.

A month after treatment, tumors in 27 of the patients (51 percent) showed a complete response, 18 (34 percent) showed a partial response and eight (15 percent) showed stable disease. Six months later 19 of 34 patients (55.9 percent) had complete tumor response, eight (23.5 percent) had a partial response and seven (20.5 percent) had growing disease. Of the remaining 19 patients, three died, four were lost at follow-up and 12 receive other treatments.

"Patients who still had good liver function and who had tumors in only one lobe of the liver did better with this treatment," said Maurizio Grosso, M.D., chairman of the Department of Radiology at Santa Croce & Carle Hospital, Cuneo, Italy. "We're hopeful that treatment with HepaSphere will be an improvement over traditional chemoembolization."

Embolization without Chemotherapy

Researchers at the European Institute of Oncology in Milan, Italy, are studying using embolization without the chemotherapy for liver cancer. The study included 25 patients with 34 primary liver tumors. All patients received Embozene(TM) microspheres alone, without the addition of any chemotherapeutic agents in the beads. The patients had 35 sessions with the microspheres. After one month follow-up, 18 tumors (52 percent) had shrunk in size while 16 (48 percent) were the same size with no tumor growth detected. In a group of 16 tumors with a follow up ranging between six and 12 months, two tumors (12 percent) completely disappeared, seven tumors (44 percent) continued to shrink, two (12 percent) were stable and five (31 percent) grew, although they were still of a size suitable for new local treatments. To date, 14 patients have had more than one year of follow-up care and 93 percent of them are still alive.

"One concern with embolization is th
'/>"/>

SOURCE International Symposium on Endovascular Therapy
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Stroke Study Reveals a Key Target For Improving Treatment
2. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
3. Reproductive Partners Participates in New IVF Progesterone Delivery System Study
4. Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer
5. Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
6. ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers
7. Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008
8. GSK Believes There Is No Liver Safety Issue With AVANDIA; Responds to Public Citizen Petition
9. Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus
10. Experts Assert That Varian Technologies Deliver Speed and Clinical Accuracy in Treating Cancer Patients
11. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 22, 2015  The Mesothelioma Victims Center is ... mesothelioma get the best possible compensation, and they are ... this rare cancer caused by exposure to asbestos ... related to treatment options such as a recent ... Mesothelioma Victims Center anytime at 866-714-6466. http://MesotheliomaVictimsCenter.Com ...
(Date:5/22/2015)... , May 22, 2015   InspireMD, Inc. ... stent embolic protection systems ("EPS"), today announced that its CGuard ... lead by principle investigator Prof. Piotr Musialek , at ... Paris, France . PARADIGM, an ... R cutaneous c A roti D revascularization I ...
(Date:5/22/2015)... 22, 2015  In a sweeping analysis assessing the ... T1D Exchange researchers conclude that there remains considerable ... across all age groups, but especially for adolescents and ... of diabetes treatment, underscoring the need to address barriers ... can help type 1 patients achieve optimal metabolic control. ...
Breaking Medicine Technology:Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5
... The American Association for Homecare urges the Joint Select ... budgetary spending cuts that will restrict access to ... to Congress. Over the years, homecare has broadened health ... cost-savings in the health care system by keeping seniors ...
... LAKES, N.J. and MONTREAL, Oct. 13, 2011 The ... Solutions, Inc. (NYSE: MHS ), and Quest ... showed a statistically significant increase in adherence to statin ... 6 (KIF6) gene testing, compared with those who did ...
Cached Medicine Technology:American Association for Homecare Calls on Joint Deficit Committee in Congress to Preserve Homecare Access for Millions of Americans 2Medco, Quest Diagnostics Personalized Medicine Study Yields Additional Clues about Patient Engagement 2Medco, Quest Diagnostics Personalized Medicine Study Yields Additional Clues about Patient Engagement 3Medco, Quest Diagnostics Personalized Medicine Study Yields Additional Clues about Patient Engagement 4
(Date:5/24/2015)... Arizona (PRWEB) May 24, 2015 ... former Millennial Media strategy executive Jay Krihak as ... Medicx looks to ramp up its expertise and ... of the Pharmaceutical and Health sectors. , Krihak ... tech executive. Most recently, Krihak led sales planning ...
(Date:5/24/2015)... Rosa, CA (PRWEB) May 24, 2015 ... a clear indicator that the single best option for ... study reveals that fitness level was the single most ... accounted for variables such as diabetes and family history ... significance of maintaining lifelong heart and lung fitness. , ...
(Date:5/23/2015)... May 23, 2015 On May 13, ... of a youngster's yogic power learned through meditation and ... Swami in Bangalore, India. , Yogamaatha, a nine-year-old girl ... 50 high profile professionals attending the 2015 Business Advocacy ... fluently -- blindfolded. , In a demonstration that ...
(Date:5/23/2015)... With the implementation of the Affordable Care ... difficult to provide their employees with a viable healthcare ... for employees stand to face strict penalties. Never before ... of a business’s success or failure. In an effort ... Doctors has created a varying level of less expensive ...
(Date:5/23/2015)... CO (PRWEB) May 23, 2015 On May ... in MuckFest. The event was a 5k mud obstacle run ... more than 2 million people worldwide, and the reason we ... community,” said Chad Davis, owner of Farrell’s eXtreme Bodyshaping. “One-hundred ... Multiple Sclerosis Society.” , The event was not only attended ...
Breaking Medicine News(10 mins):Health News:Medicx Media Solutions Expands Executive Team 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2
... DUCTZ offers advice in recognition of National Headache ... According to the National,Headache Foundation (NHF), the ... DUCTZ Indoor Air Professionals, the nation,s leading air ... between poor,indoor air quality and headache triggers. According ...
... of Non-invasive Diabetes Screening Device By Year End, ... a privately,held medical device company, announced the completion ... to $20 million to complete the company,s,pivotal clinical ... VeraLight SCOUT DS(TM) non-invasive diabetes screening system. The,current ...
... taken a major step in making the use of artificial ... a study published in the June 2008 print issue of ... developed this artificial graft tissue by combining man-made materials with ... it can attach to host tissue. , "Obviously this advance ...
... Va. and BOSTON, June 3 Most U.S.,medical ... caused by,pharmaceutical industry marketing. Only 21 of 150 ... (AMSA) have strong policies,(those graded A or B), ... AMSA collaborated with The Prescription Project, an industry ...
... joimax(R) company in,Karlsruhe, Germany, is the first company ... for the treatment of spinal canal,stenosis. Having this ... narrow the spinal canal and drastically limit,the motoric ... so called 360,degree TESSYS(TM) Spinal Stenosis System, which ...
... childhood pneumococcal conjugate vaccine has been a boon in ... and the medical community must not get complacent, as ... rise, say scientists at a meeting today in Boston. ... the total burden of pneumococcal disease. It targets ...
Cached Medicine News:Health News:Poor Indoor Air Quality Can Be Excellent Headache Trigger 2Health News:VeraLight Secures $20 Million Series C Financing 2Health News:VeraLight Secures $20 Million Series C Financing 3Health News:Scientists develop 'cyborg engineering' for coronary bypass grafting 2Health News:AMSA PharmFree Scorecard Grades U.S. Medical Schools on Conflict-of-Interest Policies; Only 7 Receive an 'A' 2Health News:AMSA PharmFree Scorecard Grades U.S. Medical Schools on Conflict-of-Interest Policies; Only 7 Receive an 'A' 3Health News:AMSA PharmFree Scorecard Grades U.S. Medical Schools on Conflict-of-Interest Policies; Only 7 Receive an 'A' 4Health News:joimax(R) Revolutionizes Spine Surgery With the Launch of Newest and Fully-Endoscopic Product Innovations to Treat Spinal Canal Stenosis 2Health News:joimax(R) Revolutionizes Spine Surgery With the Launch of Newest and Fully-Endoscopic Product Innovations to Treat Spinal Canal Stenosis 3Health News:Despite vaccine, public should not get complacent about pneumococcal disease 2
Ammonia reagent is used for the quantitative and enzymatic determination of ammonia in human plasma....
The ProteomeLab PA 800 resolves and quantifies proteins by their isoelectric point and molecular weight, generates high-resolution peptide maps and carbohydrate profiles and provides front-end separa...
Intended for the quantitative determination of triglycerides in serum or plasma. Reaction: endpoint, reaction is complete in five minutes at 37C. Wavelength: 540 nm. Linearity: 1000 mg/dL (11.3 mmol/...
For the quantitative determination of alkaline phosphatase in human serum....
Medicine Products: